FDA Approves Epidiolex to Treat Tuberous Sclerosis Complex
Mon / Aug 3rd
The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.
Cannabidiol (CBD) is one of the many cannabinoids found in cannabis. It has known medical properties and has been used by patients to treat a large number of medical conditions. Below you will find the latest CBD industry and policy news from around the world:
Mon / Aug 3rd
The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.
Tue / Jul 28th
The European Commission is considering labeling foods that contain hemp-derived CBD as “narcotic-related.” In the meantime, the commission has suspended applications for novel food products containing non-synthetic CBD.
Mon / Jul 27th
Clint Eastwood is suing a host of CBD companies for allegedly using his name and likeness to promote their products without his permission.
Thu / Jul 23rd
New research by Israeli firms Eybna and CannaSoul Analytics suggests that a combination of CBD and terpenes might be effective against the deadly cytokine storms that are symptomatic of COVID-19.
Wed / Jul 22nd
The FDA has opened public comments for new preliminary guidance from the agency for cannabis pharmaceutical research.
Mon / Jul 20th
Full-spectrum hemp oil brand Synchronicity has become the first CBD company to land a partnership with the United Soccer League.
Fri / Jul 10th PARTNER CONTENT
As an editor of West of Wild, an online publication dedicated to helping high-performing women optimize their day, I’ve tried… Read More
Thu / Jul 9th INTERVIEW
Breck Speed is COO and Cameron Meshell is President of Farmington Research, which specializes in water-soluble hemp extracts for creating CBD-infused beverage products.
Fri / Jul 3rd
A recent survey of more than 1,450 CBD consumers revealed that most use CBD to treat chronic pain, and 84% believe CBD is an effective replacement for opioids.
Wed / Jul 1st INTERVIEW
Dr. Thomas Macsay is a naturopath and medical advisor for Neurogan, a health-minded CBD company with Scandinavian roots.
Thu / Jun 18th
Louisiana Gov. Edwards signed legislation this week that regulates hemp and CBD products, including a ban on selling hemp products “for inhalation” except for hemp-based rolling papers.
Tue / Jun 9th
The FTC has filed a rare lawsuit against CBD company Whole Leaf Organics over unfounded treatment claims made by the company.
Thu / Jun 4th
A recent industry rules update allows Illinois hemp producers to sell to licensed medical and adult-use cannabis processors.
Mon / Jun 1st
A recent study published in the journal Pain found that CBD treatment for dogs with osteoarthritis was beneficial in 9 out of 10 cases.
Tue / May 26th
Japanese company Hiro International has unveiled a new line of CBD products produced using orange peels, not hemp or cannabis.
Mon / May 25th
Science suggests that there is a relationship between the endocannabinoid system and the immune system, but researchers are still working to fully understand how and why.
Thu / May 21st INTERVIEW
Jen Jackson is the founder and CEO of Be Jubie, a Baltimore-based CBD brand that emphasizes restoration, general wellness, and social justice.
Tue / May 19th
Lawsuits tied to a 2018 crackdown on Tennessee CBD retailers can move forward after a court rejected a request by law enforcement officials to have the case thrown out.
Mon / May 18th
Summitt Labs announced last week it was voluntarily recalling Batch#730 Lot#K018 of its Kore Organic Watermelon CBD Oil Tincture.
Fri / May 15th
A European Court of Justice magistrate has ruled that EU member states cannot ban imported CBD products because the law does not consider the cannabinoid to be a narcotic drug.
Mon / May 4th
CBD brand Swissx is reportedly in contact with the Premier League Club team Everton as the firm continues to pursue sponsoring a professional soccer team.
Tue / Apr 28th
The FDA has issued warnings to two CBD companies over claims that their products could treat opioid addiction and/or replace pharmaceutical drugs.
Fri / Apr 17th
Hexo, a Canadian cannabis producer, and beer-maker Molson Coors Brewing Company have partnered for a CBD beverage joint venture in Colorado.
Thu / Apr 16th
A localized survey of 500 Hash Bash attendees in Michigan showed that even among the most enthusiastic consumers, knowledge about cannabinoid content and cannabis dosing can be very limited.
Website & branding by the Ganjapreneur in-house agency:
Uplifted cannabis industry branding & marketing.